US FDA backs Pfizer's Covid-19 booster shot for 12- to 15-year-olds

US FDA backs Pfizer's Covid-19 booster shot for 12- to 15-year-olds

MARYLAND: The U.S. Food and Drug Administration has authorised the use of a third dose of the Pfizer and BioNTech Covid-19 vaccine for children aged between 12 and 15 years, and narrowed the time for all booster shots by a month to five months after the primary doses.

© New Straits Times Press (M) Bhd

Scroll to Top